1. Home
  2. CRVO vs GCTS Comparison

CRVO vs GCTS Comparison

Compare CRVO & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVO
  • GCTS
  • Stock Information
  • Founded
  • CRVO 2001
  • GCTS 1998
  • Country
  • CRVO United States
  • GCTS United States
  • Employees
  • CRVO N/A
  • GCTS N/A
  • Industry
  • CRVO Biotechnology: Pharmaceutical Preparations
  • GCTS Blank Checks
  • Sector
  • CRVO Health Care
  • GCTS Finance
  • Exchange
  • CRVO Nasdaq
  • GCTS Nasdaq
  • Market Cap
  • CRVO 95.4M
  • GCTS 91.7M
  • IPO Year
  • CRVO N/A
  • GCTS N/A
  • Fundamental
  • Price
  • CRVO $8.49
  • GCTS $1.53
  • Analyst Decision
  • CRVO Strong Buy
  • GCTS Strong Buy
  • Analyst Count
  • CRVO 8
  • GCTS 1
  • Target Price
  • CRVO $25.43
  • GCTS $5.00
  • AVG Volume (30 Days)
  • CRVO 453.1K
  • GCTS 186.5K
  • Earning Date
  • CRVO 05-20-2025
  • GCTS 05-14-2025
  • Dividend Yield
  • CRVO N/A
  • GCTS N/A
  • EPS Growth
  • CRVO N/A
  • GCTS N/A
  • EPS
  • CRVO N/A
  • GCTS N/A
  • Revenue
  • CRVO $9,737,974.00
  • GCTS $9,128,000.00
  • Revenue This Year
  • CRVO N/A
  • GCTS $315.69
  • Revenue Next Year
  • CRVO N/A
  • GCTS $170.56
  • P/E Ratio
  • CRVO N/A
  • GCTS N/A
  • Revenue Growth
  • CRVO 36.29
  • GCTS N/A
  • 52 Week Low
  • CRVO $1.80
  • GCTS $1.16
  • 52 Week High
  • CRVO $25.69
  • GCTS $6.32
  • Technical
  • Relative Strength Index (RSI)
  • CRVO 46.29
  • GCTS 53.34
  • Support Level
  • CRVO $8.40
  • GCTS $1.38
  • Resistance Level
  • CRVO $11.79
  • GCTS $1.44
  • Average True Range (ATR)
  • CRVO 0.99
  • GCTS 0.06
  • MACD
  • CRVO -0.19
  • GCTS 0.03
  • Stochastic Oscillator
  • CRVO 10.45
  • GCTS 85.29

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

About GCTS GCT Semiconductor Holding Inc. Common Stock

GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

Share on Social Networks: